# SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE
> **ANDA207678** · Abbreviated New Drug Application (Generic) · Sponsor: DR REDDYS LABS SA · Approved 2023-08-09
## Drug
- **FDA Application Number:** ANDA207678
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE
- **Generic name:** SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE
- **Active ingredients:** METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** DR REDDYS LABS SA
- **Manufacturer:** Dr.Reddys Laboratories Inc
- **First approval:** 2023-08-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207678)
---
*MORVS · CC0 1.0*